This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Other hereditary or degenerative neurological diso...
  • /
  • Safety and efficacy of edaravone in well defined p...
Journal

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Read time: 2 mins
Published:1st Jul 2017
Author: Abe K, Aoki M, Tsuji S, Itoyama Y, Sobue G, Togo M et al.
Availability: Pay for access, or by subscription
Ref.:Lancet Neurol. 2017;16(7):505-512.
DOI:10.1016/S1474-4422(17)30115-1
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest